Erika Lerch, MD, Ulrich R. Müller, MD 

Slides:



Advertisements
Similar presentations
Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
Advertisements

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy  Monica B. Arvidsson, MD, Olle.
Shin-Ichi Nishikawa, MD, PhD 
Kiwi fruit allergy: A new birch pollen–associated food allergy
Evaluation and treatment of allergic fungal sinusitis. II
Modulation of T-cell response to phospholipase A2 and phospholipase A2–derived peptides by conventional bee venom immunotherapy  Regine Kämmerer, MDa,b,
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy  Marcel Frick, MS, Jörg Fischer, MD, Arthur Helbling,
Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.
Kiwi fruit allergy: A new birch pollen–associated food allergy
Ulf Darsow, MD, Dieter Vieluf, MD, Johannes Ring, MD, PhD 
Evaluation and treatment of allergic fungal sinusitis. II
Rosa Codina, PhD, Richard F. Lockey, MD 
Youngil I. Koh, MD a, Inseon S
Practice Notes from the AAAI
Badrul A. Chowdhury, MD, PhD 
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Allergy to eggs from duck and goose without sensitization to hen egg proteins  Belén Añíbarro, MD, F.Javier Seoane, MD, Concepción Vila, MD, Manuel Lombardero,
Elephantiasis nostras: A case report
Conjunctivitis medicamentosa
Paul Van Durme, MDa, Jan L. Ceuppens, MD, PhDa,b, Pascal Cadot, PhDb 
Practice Notes from the AAAAI
A methodological assessment of diurnal variability of peak flow as a basis for comparing different inhaled steroid formulations  John H. Toogood, MD,
Phillip Lieberman, MD, Michael Tankersley, MD 
Robert A. Wood, MD, Wanda Phipatanakul, MD, Robert G
A review of the current guidelines for allergic rhinitis and asthma
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Early decreases in blood eosinophil levels with reslizumab
News & Notes Journal of Allergy and Clinical Immunology
Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: Conversion with immunotherapy and relation to.
IgE autoantibodies monitored in a patient with atopic dermatitis under cyclosporin A treatment reflect tissue damage  Tamar Kinaciyan, MD a*, Susanne.
Phillip Lieberman, MD, David Golden, MD 
Direct exposure of carpets to sunlight can kill all mites
Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization  Qutayba Hamid, MD, PhD, Editor  Journal.
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma  Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.
Natural history of Hymenoptera venom sensitivity in adults
Trichophyton -specific IgE in patients with dermatophytosis is not associated with aeroallergen sensitivity  Maria Teresa Escalante, MD, Mario Sánchez-Borges,
Mary Elizabeth Bollinger, DO, Robert G. Hamilton, PhD, Robert A
Patterns of pollen cross-allergenicity
Molecular virology and immunology of HIV infection
Exercise-induced bronchoconstriction in children: Montelukast attenuates the immediate-phase and late-phase responses  Raul E. Melo, MD, Dirceu Solé,
Vascular endothelial growth factor in patients with acute asthma
Childhood allergic bronchopulmonary aspergillosis
Autophagy: Nobel Prize 2016 and allergy and asthma research
Addition of mycophenolate mofetil to tacrolimus is associated with decreases in food- specific IgE levels in a pediatric patient with liver transplantation-associated.
News & Notes Journal of Allergy and Clinical Immunology
Advances in the approach to the patient with food allergy
Modulation of T-cell response to phospholipase A2 and phospholipase A2–derived peptides by conventional bee venom immunotherapy  Regine Kämmerer, MDa,b,
Association of humoral immunodeficiency, cleidocranial dysplasia, and von Willebrand’s disease in a family cluster  Pramod S. Kelkar, MD, Rosa M. Ten,
Observations on emerging patterns of asthma in our society
Occupational allergy caused by urticating hair of Brazilian spider
The 30th anniversary of the American Board of Allergy and Immunology: Then and now  Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.
Emma Broadfield, MRCP, Tricia M
Renata J. M. Engler, MDa, Julie Kenner, MD, PhDb, Donald Y. M
Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective  Helen Donohoe, MSc (Econ) 
Practice Notes from the AAAI
Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy  Ulrich R. Müller, MD, Marek Jutel, MD,
Determinants of systemic manifestations of food allergy
Atopy patch tests, together with determination of specific IgE levels, reduce the need for oral food challenges in children with atopic dermatitis  Charles.
Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma  Sally E. Wenzel, MD  Journal of Allergy and Clinical.
Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy  Diane J. Pincus, MD, Teresa R. Humeston,
Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M
Footnotes1 Journal of Allergy and Clinical Immunology
Evelyn Farinas, RPh, MGA, Peter Honig, MD 
The environmental predictors of allergic disease
Pioneers and milestones
Bruce K. Bacot, MD, Mary E. Paul, MD, Maritza Navarro, MD, Stuart L
News & Notes Journal of Allergy and Clinical Immunology
The kinetics of change in cytokine production by CD4+ T cells during conventional allergen immunotherapy  Suwat Benjaponpitak, MDa*, Amy Oro, MDa*, Peter.
Presentation transcript:

Long-term protection after stopping venom immunotherapy: Results of re-stings in 200 patients  Erika Lerch, MD, Ulrich R. Müller, MD  Journal of Allergy and Clinical Immunology  Volume 101, Issue 5, Pages 606-612 (May 1998) DOI: 10.1016/S0091-6749(98)70167-8 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Skin test EPCs (arithmetic mean values) to BV (above) and VV (below) in patients with relapse (BV, n = 19; VV, n = 6) and continued protection (BV, n = 38; VV, n = 12). Significant decrease during VIT (p < 0.01) is observed in protected patients and patients with relapse on VIT with BV and in protected patients on VIT with VV. No significant difference between patients with relapse and continued protection is found at any time. Journal of Allergy and Clinical Immunology 1998 101, 606-612DOI: (10.1016/S0091-6749(98)70167-8) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Specific IgE (geometric mean values) to BV (above) and VV (below) in patients with relapse (BV, n = 19; VV, n = 6) and continued protection (BV, n = 38; VV, n = 12). Significant decrease of sIgE during VIT is observed for patients with relapse and continued protection on VIT with BV (p < 0.01). There is only an insignificant further decrease after stopping VIT. At no time is there any significant difference between patients with relapse and continued protection. Journal of Allergy and Clinical Immunology 1998 101, 606-612DOI: (10.1016/S0091-6749(98)70167-8) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 Specific IgG (geometric mean values) to BV (above) and to VV (below) in patients with relapse (BV, n = 19; VV, n = 6) and continued protection (BV, n = 38; VV, n  = 12). Slight but insignificant increase of sIgG is observed in all groups during VIT and strong decrease after its termination, which reaches statistical significance (p < 0.03) in both groups after treatment with BV. At no time is there significant difference between patients with relapse and continued protection. Journal of Allergy and Clinical Immunology 1998 101, 606-612DOI: (10.1016/S0091-6749(98)70167-8) Copyright © 1998 Mosby, Inc. Terms and Conditions